Xiao-cang J. Ren
Renqiu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer.
Journal: BMJ open
Published: October 25, 2020
High-intensity focused ultrasound combined with transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma: A case report.
Journal: Medicine
Published: August 03, 2019
Cryoablation combined with radiotherapy for hepatic malignancy: Five case reports.
Journal: World journal of gastrointestinal oncology
Published: May 21, 2019
The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: March 14, 2019
Progress in image-guided radiotherapy for the treatment of non-small cell lung cancer.
Journal: World journal of radiology
Published: October 29, 2018
Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial.
Journal: BMC cancer
Published: March 03, 2015
Treating advanced non-small-cell lung cancer in Chinese patients: focus on icotinib.
Journal: OncoTargets and therapy
Published: May 31, 2014
High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.
Journal: Radiation oncology (London, England)
Published: May 05, 2013
Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial.
Journal: Radiation oncology (London, England)
Published: March 30, 2013
Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer.
Journal: Radiation oncology (London, England)
Published: March 03, 2013
Phase II trial of capecitabine combined with docetaxel in previously treated patients with non-small cell lung cancer: A randomized controlled study.
Journal: Oncology letters
Published: November 14, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026